Cargando…
YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multi-center randomized controlled trial
INTRODUCTION: Hepatitis B-related compensated liver cirrhosis is related to a higher risk of hepatocellular carcinoma, and antiviral therapy is the preferred method. As the pathological mechanisms of liver fibrosis are complex, drugs developed for a single target are difficult to be effective in cli...
Autores principales: | Wu, Qing-Juan, Lv, Wen-Liang, Li, Juan-Mei, Zhang, Ting-Ting, Zhou, Wen-Hui, Zhang, Qiang, Wang, Jiu-Chong, Wang, Qing-Nan, Yao, Zi-Ang, Qiang, Rui, Chen, Si-Tong, Zhao, Xin, Liu, Shuang, Cao, Zheng-Min, Xu, Lei, Li, Gao-Hui, Chen, Jing, Wang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515328/ https://www.ncbi.nlm.nih.gov/pubmed/34649610 http://dx.doi.org/10.1186/s13063-021-05650-6 |
Ejemplares similares
-
Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial
por: Wu, Qing-Juan, et al.
Publicado: (2020) -
Effects of Huang Qi Decoction on Endothelial Dysfunction Induced by Homocysteine
por: Chu, Shuang, et al.
Publicado: (2016) -
Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment
por: Zhang, Jingsi, et al.
Publicado: (2018) -
Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway
por: Liu, Kun, et al.
Publicado: (2019) -
A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy
por: Di, Sha, et al.
Publicado: (2018)